Metastatic SMARCA4-deficient undifferentiated tumor in the small mesentery: case report

World J Surg Oncol. 2024 Dec 20;22(1):337. doi: 10.1186/s12957-024-03619-8.

Abstract

Background: SMARCA4-deficient undifferentiated tumor (SMARCA4-UT) is a rare and highly malignant primary tumor characterized by the loss of SMARCA4 expression. Despite advancements in oncology, diagnosing and treating SMARCA4-UT remain significant clinical challenges.

Case demonstration: A 67-year-old male with a history of smoking presented to the hospital with complaints of abdominal distention and pain lasting for more than four days. Abdominal computed tomography (CT) revealed a high-density mass measuring approximately 41 × 37 mm in the right lower quadrant. Additionally, chest CT identified a high-density mass measuring 63 × 48 mm in the upper lobe of the right lung. The patient underwent partial small bowel resection, and postoperative pathological examination confirmed a diagnosis of SMARCA4-UT originating in the small mesentery. Unfortunately, the patient succumbed to respiratory failure 21 days after the diagnosis.

Conclusion: SMARCA4-UT is an exceedingly rare and aggressive undifferentiated tumor. This case highlights a presentation of SMARCA4-UT with abdominal pain and distention as initial symptoms. Clinicians should consider SMARCA4-UT in middle-aged or elderly male patients with a history of smoking who present with large masses. Comprehensive chest imaging is essential to exclude the thoracic primary disease in such cases.

Keywords: SMARCA4; SMARCA4-deficient undifferentiated tumors; Diagnosis; Gastrointestinal symptoms; Intestine.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • DNA Helicases* / genetics
  • Fatal Outcome
  • Humans
  • Lung Neoplasms / pathology
  • Lung Neoplasms / surgery
  • Male
  • Mesentery* / pathology
  • Mesentery* / surgery
  • Nuclear Proteins / deficiency
  • Nuclear Proteins / genetics
  • Peritoneal Neoplasms / diagnosis
  • Peritoneal Neoplasms / pathology
  • Peritoneal Neoplasms / secondary
  • Peritoneal Neoplasms / surgery
  • Prognosis
  • Tomography, X-Ray Computed
  • Transcription Factors* / deficiency
  • Transcription Factors* / genetics

Substances

  • SMARCA4 protein, human
  • DNA Helicases
  • Transcription Factors
  • Nuclear Proteins